Skip to main content
SpringerLink
Log in

Regular Use of Aspirin and Prostate Cancer Risk (United States)

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

It has been hypothesized that aspirin and other nonsteroidal anti-inflammatory drugs can decrease the risk of developing prostate and other cancers, although observational studies have not been very conclusive. The current study examined the effects of regular aspirin use on prostate cancer risk in 1,029 patients with primary, incident cancer of the prostate and 1,029 hospital controls frequency-matched to cases by 5-year age group and period of questionnaire completion. Patients who reported use of aspirin for at least once a week for at least 6 months were classified as regular users, with others classified as non-users. Results indicate that regular aspirin use may not be associated with decreased prostate cancer risk [odds ratio (OR) 1.05, 95% confidence interval (CI) 0.89–1.25], frequency of use (OR for at least seven/week 0.91, 95% CI 0.73–1.13), duration of use (OR for at least 10 years of use 1.17 95% CI 0.93–1.46) or tablet years (defined as tablets per day x years of use). A similar lack of association was observed when analyses were performed examining stage of the cancer. These data suggest that aspirin use may not be associated with reduced risk of prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor et al. (2005) ArticleTitleCancer statistics, 2005 CA Cancer J Clin 55 IssueID1 10–30 Occurrence Handle15661684

    PubMed  Google Scholar 

  2. DG Bostwick HB Burke D Djakiew S Euling SM Ho J Landolph et al. (2004) ArticleTitleHuman prostate cancer risk factors Cancer 101 IssueID10 Suppl 2371–2490 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGmtbnF Occurrence Handle15495199

    CAS  PubMed  Google Scholar 

  3. MJ Thun SJ Henley C Patrono (2002) ArticleTitleNonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 IssueID4 252–266 Occurrence Handle1:CAS:528:DC%2BD38Xit1ygtb8%3D Occurrence Handle11854387

    CAS  PubMed  Google Scholar 

  4. A Kirschenbaum X Liu S Yao AC Levine (2001) ArticleTitleThe role of cyclooxygenase-2 in prostate cancer Urology 58 IssueID2 Suppl 1 127–131 Occurrence Handle1:STN:280:DC%2BD3Mvlslehtg%3D%3D Occurrence Handle11502467

    CAS  PubMed  Google Scholar 

  5. S Gupta M Srivastava N Ahmad DG Bostwick H Mukhtar (2000) ArticleTitleOver-expression of cyclooxygenase-2 in human prostate adenocarcinoma Prostate 42 IssueID1 73–78 Occurrence Handle10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G Occurrence Handle1:CAS:528:DC%2BD3cXisVCqtw%3D%3D Occurrence Handle10579801

    Article  CAS  PubMed  Google Scholar 

  6. R Yoshimura H Sano C Masuda M Kawamura Y Tsubouchi J Chargui et al. (2000) ArticleTitleExpression of cyclooxygenase-2 in prostate carcinoma Cancer 89 IssueID3 589–596 Occurrence Handle10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C Occurrence Handle1:CAS:528:DC%2BD3cXlvFCktLc%3D Occurrence Handle10931458

    Article  CAS  PubMed  Google Scholar 

  7. S Zha WR Gage J Sauvageot EA Saria MJ Putzi CM Ewing et al. (2001) ArticleTitleCyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma Cancer Res 61 IssueID24 8617–8623 Occurrence Handle1:CAS:528:DC%2BD38Xht1Ohtg%3D%3D Occurrence Handle11751373

    CAS  PubMed  Google Scholar 

  8. T Hussain S Gupta H Mukhtar (2003) ArticleTitleCyclooxygenase-2 and prostate carcinogenesis Cancer Lett 191 IssueID2 125–135 Occurrence Handle10.1016/S0304-3835(02)00524-4 Occurrence Handle1:CAS:528:DC%2BD3sXhs1Klsbs%3D Occurrence Handle12618325

    Article  CAS  PubMed  Google Scholar 

  9. SK Pathak RA Sharma WP Steward JK Mellon TR Griffiths AJ Gescher (2005) ArticleTitleOxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies Eur J Cancer 41 IssueID1 61–70 Occurrence Handle10.1016/j.ejca.2004.09.028 Occurrence Handle1:CAS:528:DC%2BD2MXhtVCqug%3D%3D Occurrence Handle15617991

    Article  CAS  PubMed  Google Scholar 

  10. M Tsujii RN DuBois (1995) ArticleTitleAlterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 IssueID3 493–501 Occurrence Handle10.1016/0092-8674(95)90127-2 Occurrence Handle1:CAS:528:DyaK2MXpt1Olt7w%3D Occurrence Handle8521479

    Article  CAS  PubMed  Google Scholar 

  11. RR Tjandrawinata M Hughes-Fulford (1997) ArticleTitleUp-regulation of cyclooxygenase-2 by product-prostaglandin E2 Adv Exp Med Biol 407 163–170 Occurrence Handle1:CAS:528:DyaK1cXhsFCitrc%3D Occurrence Handle9321948

    CAS  PubMed  Google Scholar 

  12. XH Liu A Kirschenbaum M Lu S Yao A Klausner C Preston et al. (2002) ArticleTitleProstaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway Biochem Biophys Res Commun 290 IssueID1 249–255 Occurrence Handle1:CAS:528:DC%2BD38XhsFCgtw%3D%3D Occurrence Handle11779161

    CAS  PubMed  Google Scholar 

  13. MJ Thun MM Namboodiri EE Calle WD Flanders CW Heath SuffixJr (1993) ArticleTitleAspirin use and risk of fatal cancer Cancer Res 53 IssueID6 1322–1327 Occurrence Handle1:CAS:528:DyaK3sXktl2qtLY%3D Occurrence Handle8443812

    CAS  PubMed  Google Scholar 

  14. DM Schreinemachers RB Everson (1994) ArticleTitleAspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 IssueID2 138–146 Occurrence Handle1:STN:280:ByuB38jhsFU%3D Occurrence Handle8172988

    CAS  PubMed  Google Scholar 

  15. AE Norrish RT Jackson CU McRae (1998) ArticleTitleNon-steroidal anti-inflammatory drugs and prostate cancer progression Int J Cancer 77 IssueID4 511–555 Occurrence Handle10.1002/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X Occurrence Handle1:CAS:528:DyaK1cXkslKiuro%3D Occurrence Handle9679750

    Article  CAS  PubMed  Google Scholar 

  16. MJ Langman KK Cheng EA Gilman RJ Lancashire (2000) ArticleTitleEffect of anti-inflammatory drugs on overall risk of common cancer: case–control study in general practice research database BMJ 320 IssueID7250 1642–1646 Occurrence Handle10.1136/bmj.320.7250.1642 Occurrence Handle1:STN:280:DC%2BD3czhsVejsQ%3D%3D Occurrence Handle10856067

    Article  CAS  PubMed  Google Scholar 

  17. JE Nelson RE Harris (2000) ArticleTitleInverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case–control study Oncol Rep 7 IssueID1 169–170 Occurrence Handle1:STN:280:DC%2BD3c%2FntVKjtQ%3D%3D Occurrence Handle10601612

    CAS  PubMed  Google Scholar 

  18. LA Habel W Zhao JL Stanford (2002) ArticleTitleDaily aspirin use and prostate cancer risk in a large, multiracial cohort in the US Cancer Causes Control 13 IssueID5 427–434 Occurrence Handle10.1023/A:1015788502099 Occurrence Handle12146847

    Article  PubMed  Google Scholar 

  19. J Irani V Ravery JL Pariente E Chartier-Kastler E Lechevallier M Soulie et al. (2002) ArticleTitleEffect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk J Urol 168 IssueID5 1985–1988 Occurrence Handle10.1016/S0022-5347(05)64277-2 Occurrence Handle1:CAS:528:DC%2BD38XotFKrsLY%3D Occurrence Handle12394690

    Article  CAS  PubMed  Google Scholar 

  20. MF Leitzmann MJ Stampfer J Ma JM Chan GA Colditz WC Willett et al. (2002) ArticleTitleAspirin use in relation to risk of prostate cancer Cancer Epidemiol Biomarkers Prev 11 IssueID10 Pt 1 1108–1111 Occurrence Handle1:CAS:528:DC%2BD38Xos1eku78%3D Occurrence Handle12376516

    CAS  PubMed  Google Scholar 

  21. RO Roberts DJ Jacobson CJ Girman T Rhodes MM Lieber SJ Jacobsen (2002) ArticleTitleA population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer Mayo Clin Proc 77 IssueID3 219–225 Occurrence Handle11888024

    PubMed  Google Scholar 

  22. L Perron I Bairati L Moore F Meyer (2003) ArticleTitleDosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer Int J Cancer 106 IssueID3 409–415 Occurrence Handle10.1002/ijc.11250 Occurrence Handle1:CAS:528:DC%2BD3sXlvF2hsrs%3D Occurrence Handle12845682

    Article  CAS  PubMed  Google Scholar 

  23. LA Garcia Rodriguez A Gonzalez-Perez (2004) ArticleTitleInverse association between nonsteroidal anti-inflammatory drugs and prostate cancer Cancer Epidemiol Biomarkers Prev 13 IssueID4 649–653 Occurrence Handle1:CAS:528:DC%2BD2cXivVSitrc%3D Occurrence Handle15066932

    CAS  PubMed  Google Scholar 

  24. EA Platz S Rohrmann JD Pearson MM Corrada DJ Watson AM Marzo ParticleDe et al. (2005) ArticleTitleNonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging Cancer Epidemiol Biomarkers Prev 14 IssueID2 390–396 Occurrence Handle10.1158/1055-9965.EPI-04-0532 Occurrence Handle1:CAS:528:DC%2BD2MXhs1Ghs7Y%3D Occurrence Handle15734963

    Article  CAS  PubMed  Google Scholar 

  25. A Gonzalez-Perez LA Garcia Rodriguez R Lopez-Ridaura (2003) ArticleTitleEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis BMC Cancer 3 IssueID1 28 Occurrence Handle14588079

    PubMed  Google Scholar 

  26. S Mahmud E Franco A Aprikian (2004) ArticleTitleProstate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis Br J Cancer 90 IssueID1 93–99 Occurrence Handle10.1038/sj.bjc.6601416 Occurrence Handle1:CAS:528:DC%2BD2cXhtFKgsw%3D%3D Occurrence Handle14710213

    Article  CAS  PubMed  Google Scholar 

  27. C Mettlin N Natarajan R Huben (1990) ArticleTitleVasectomy and prostate cancer risk Am J Epidemiol 132 IssueID6 1056–1061 Occurrence Handle1:STN:280:By6D1c3nvVQ%3D Occurrence Handle2260537

    CAS  PubMed  Google Scholar 

  28. TL Cornelison N Natarajan MS Piver CJ Mettlin (1997) ArticleTitleTubal ligation and the risk of ovarian carcinoma Cancer Detect Prev 21 IssueID1 1–6 Occurrence Handle1:STN:280:ByiC1Mnms1M%3D Occurrence Handle9043756

    CAS  PubMed  Google Scholar 

  29. KB Moysich C Mettlin MS Piver N Natarajan RJ Menezes H Swede (2001) ArticleTitleRegular use of analgesic drugs and ovarian cancer risk Cancer Epidemiol Biomarkers Prev 10 IssueID8 903–906 Occurrence Handle1:STN:280:DC%2BD3Mvktlahuw%3D%3D Occurrence Handle11489759

    CAS  PubMed  Google Scholar 

  30. O Suh C Mettlin NJ Petrelli (1993) ArticleTitleAspirin use, cancer, and polyps of the large bowel Cancer 72 IssueID4 1171–1177 Occurrence Handle1:STN:280:ByyA3sflvFM%3D Occurrence Handle8339210

    CAS  PubMed  Google Scholar 

  31. C Mettlin I Croghan N Natarajan W Lane (1990) ArticleTitleThe association of age and familial risk in a case–control study of breast cancer Am J Epidemiol 131 IssueID6 973–983 Occurrence Handle1:STN:280:By%2BB287ntVc%3D Occurrence Handle2343868

    CAS  PubMed  Google Scholar 

  32. C Mettlin (1989) ArticleTitleMilk drinking, other beverage habits, and lung cancer risk Int J Cancer 43 IssueID4 608–612 Occurrence Handle1:STN:280:BiaC1MjjvVQ%3D Occurrence Handle2703270

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, Roswell Park Cancer Institute, A-316 Carlton House, Elm and Carlton Streets, Buffalo, NY, 14263

    Ravi J. Menezes, Robert Niles & Kirsten B. Moysich

  2. Department of Epidemiology and Public Health, Yale University, New Haven, CT, 06520, USA

    Helen Swede

Authors
  1. Ravi J. Menezes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen Swede
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Niles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kirsten B. Moysich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kirsten B. Moysich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Menezes, R.J., Swede, H., Niles, R. et al. Regular Use of Aspirin and Prostate Cancer Risk (United States). Cancer Causes Control 17, 251–256 (2006). https://doi.org/10.1007/s10552-005-0450-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-005-0450-z

Keywords

Search

Navigation